EDUCATION
Diploma, 1971, Miami Valley Hospital School of Nursing
Certificate Nurse Practitioner, 1989, Mountain Area Health Education Center
B.S.N., 1990, University of New Mexico
M.S.N., 1996, University of New Mexico

PROFESSIONAL CERTIFICATION
Registered Nurse, State of New Mexico
Certified Clinical Research Coordinator (ACRP)

EMPLOYMENT

PROFESSIONAL AFFILIATIONS
American Nurses Association
New Mexico Nurses Association

REPRESENTATIVE RESEARCH PROJECTS

1. A 24 Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of 18 mcg of (study drug) Inhalation Capsules Administered by Handihaler Once-Daily plus PRN Albuterol (Salbutamol) HFA vs. Placebo plus PRN Albuterol (Salbutamol) HFA in Chronic Obstructive Pulmonary Disease (COPD) Subjects Naive to Maintenance Therapy, 2007.

    

2. A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Demonstrate the Subjective Treatment Effects of (study drug) on Sleep Using a Post Sleep Questionnaire-Interactive Voice Response System (PSQ-IVRS) in an “At-Home Setting” in an Adult Population with Chronic Insomnia, 2007.

    

3. A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Multiple Doses of (study drug) Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects with Type 2 Diabetes Mellitus, 2007.

    

4. Fifty-two Weeks, Open-Label Extension Trial to Evaluate Safety and Efficacy of (study drug) in Outpatients with Chronic Primary Insomnia who Completed Clinical Trial Protocols, 2007.

    

5. A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 2 Different Transdermal Doses of (study drug) in Subjects with Signs and Symptoms Associated with Fibromyalgia Syndrome, 2007.

    

6. A Long-Term Safety Study of a Combination Product Containing (study drug) and (study drug) for the Treatment of Migraine in Adolescents, 2007.

    

7. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of (study drug) in Subjects with Essential Hypertension, 2007.

    

8. Open-Label Extension, Single-Arm, Flexible-Dosing, Phase III Trial with (study drug) Extended-Release (ER) in Subjects with Moderate to Severe Chronic Pain, 2007.

    

9. A Multicenter Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of (study drug) in Moderately Obese Hyperlipidemic Patients with or without Concomitant Atorvastatin, 2007.

    

10. A Randomized, Double-Blind Placebo-Controlled Dose Escalation Study of (study drug) 100 and 200 mg Daily in Patients with Fibromyalgia: Effects on 24-Hour Ambulatory Blood Pressure Monitoring, 2007.

     

11. A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of (study drug) Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects, 2007.

     

12. A Multinational, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Efficacy and Safety Comparison over 24 Weeks of Three Doses (50 mg, 100 mg, 200 mg) of (study drug) to Tiotropium 5 mg and Placebo Delivered by the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease (COPD), 2007.

     

13. A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial of (study drug) in Adults with Primary Insomnia, 2007.

     

14. A 2-Month Safety Follow-up Trial of Subjects from Mannkind Protocols, 2007.

     

15. A Randomized, Double-Blind, Double-Dummy Placebo-Controlled, Crossover Study to Evaluate the Efficacy of (study drug) versus (study drug) for the Acute Treatment of Migraine when Administered During the Moderate-Severe Pain Phase of Migraine, 2008.

     

16. A 16-Week , Phase 1, Multicenter, Double-Blind, Randomized, (study drug) Controlled, Parallel-Group Pharmacological Study, to Assess the Effect of (study drug) (375 mg and 750 mg, bid) Compared to Equimolar Doses of (study drug) (250 mg and 500 mg, bid) and to (study drug) (600 mg, tid) on Arterial Blood Pressure as Measured by Ambulatory Blood Pressure Monitoring in Osteoarthritis Patients with Controlled Essential Hypertension, 2008.

     

17. A 24-Week (+ 24 week extension), Randomised, Placebo-Controlled (only 1st 12-week period), Double-Blind, Parallel-Group, Efficacy and Safety Comparison of (study drug) (7.5 mg/25 mg) Inhalation Powder in the Morning (PE capsule via tiotropium/salmeterol HandiHaler®), (study drug) (18 mg) Inhalation Powder in the Morning (gelatine capsule via Spiriva® HandiHaler®), (study drug) (25 mg) Powder in the Morning and Evening (PE capsule via tiotropium/salmeterol HandiHaler®) and (study drug) (7.5 mg/25 mg) Inhalation Powder in the Morning (PE capsule via (study drug) HandiHaler®) plus (study drug) (25 mg) Inhalation Powder in the Evening (PE capsule via (study drug) HandiHaler®) in Patients with COPD, 2008.

     

18. A Randomized, Double-Blind, Placebo-Controlled, Double-Dummy, Parallel-Group, Multicenter, Dose-Ranging Study in Subjects with Type 2 Diabetes Mellitus to Evaluate the Efficacy, Safety, and Tolerability of Orally-Administered (study drug) with (study drug) as a Reference Arm IND, 2008.

     

19. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment with (study drug) 20 mg qd to Placebo qd in Patients with Heartburn and Sleep Disturbances Associated with Gastroesophageal Reflux Disease (GERD), 2008.

     

20. A Dose-Response Study of (study drug) Compared with Concurrent Placebo Control and Lyrica (pregabalin), in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy (DPN).

     

21. An Efficacy and Safety Study of (study drug) Compared with a Concurrent Placebo Control in Subjects with Neuropathic Pain Associated with Post-Herpetic Neuralgia (PHN), 2008.